Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5675
pubmed:dateCreated
2004-5-28
pubmed:abstractText
"Cross-priming" describes the activation of naïve CD8+ T cells by professional antigen-presenting cells that have acquired viral or tumor antigens from "donor" cells. Antigen transfer is believed to be mediated by donor cell-derived molecular chaperones bearing short peptide ligands generated by proteasome degradation of protein antigens. We show here that cross-priming is based on the transfer of proteasome substrates rather than peptides. These findings are potentially important for the rational design of vaccines that elicit CD8+ T cell responses.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcysteine, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Cysteine Endopeptidases, http://linkedlifedata.com/resource/pubmed/chemical/Cysteine Proteinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Molecular Chaperones, http://linkedlifedata.com/resource/pubmed/chemical/Multienzyme Complexes, http://linkedlifedata.com/resource/pubmed/chemical/Ovalbumin, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Proteasome Endopeptidase Complex, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, http://linkedlifedata.com/resource/pubmed/chemical/lactacystin
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1095-9203
pubmed:author
pubmed:issnType
Electronic
pubmed:day
28
pubmed:volume
304
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1318-21
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:15166379-Acetylcysteine, pubmed-meshheading:15166379-Animals, pubmed-meshheading:15166379-Antigen Presentation, pubmed-meshheading:15166379-Antigens, pubmed-meshheading:15166379-Antigens, Viral, pubmed-meshheading:15166379-CD8-Positive T-Lymphocytes, pubmed-meshheading:15166379-Cell Line, pubmed-meshheading:15166379-Cross-Priming, pubmed-meshheading:15166379-Cysteine Endopeptidases, pubmed-meshheading:15166379-Cysteine Proteinase Inhibitors, pubmed-meshheading:15166379-Endoplasmic Reticulum, pubmed-meshheading:15166379-Humans, pubmed-meshheading:15166379-Immunization, pubmed-meshheading:15166379-Influenza A virus, pubmed-meshheading:15166379-Lymphocyte Activation, pubmed-meshheading:15166379-Mice, pubmed-meshheading:15166379-Mice, Inbred C57BL, pubmed-meshheading:15166379-Mice, Transgenic, pubmed-meshheading:15166379-Molecular Chaperones, pubmed-meshheading:15166379-Multienzyme Complexes, pubmed-meshheading:15166379-Ovalbumin, pubmed-meshheading:15166379-Peptide Fragments, pubmed-meshheading:15166379-Proteasome Endopeptidase Complex, pubmed-meshheading:15166379-Recombinant Fusion Proteins, pubmed-meshheading:15166379-Vaccines, pubmed-meshheading:15166379-Vaccinia virus
pubmed:year
2004
pubmed:articleTitle
CD8+ T cell cross-priming via transfer of proteasome substrates.
pubmed:affiliation
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda MD, 20892-0440, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't